An overview of the pharmacology and clinical efficacy of indapamide sustained release.

Item

http://www.wikidata.org/entity/Q36324886

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

An overview of the pharmacology and clinical efficacy of indapamide sustained release.

@ast

An overview of the pharmacology and clinical efficacy of indapamide sustained release.

@en

type

Item

label

An overview of the pharmacology and clinical efficacy of indapamide sustained release.

@ast

An overview of the pharmacology and clinical efficacy of indapamide sustained release.

@en

prefLabel

An overview of the pharmacology and clinical efficacy of indapamide sustained release.

@ast

An overview of the pharmacology and clinical efficacy of indapamide sustained release.

@en

P1476

An overview of the pharmacology and clinical efficacy of indapamide sustained release.

@en

P2093

Bataillard A

http://www.w3.org/2001/XMLSchema#string

McIntyre H

http://www.w3.org/2001/XMLSchema#string

Sassard J

http://www.w3.org/2001/XMLSchema#string

P2860

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

The role of diastolic blood pressure when treating isolated systolic hypertension

British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

A comparison of indapamide SR 1.5 mg with both amlodipine 5 mg and hydrochlorothiazide 25 mg in elderly hypertensive patients: a randomized double-blind controlled study.

Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European study group.

Twenty-four hour antihypertensive efficacy of indapamide, 1.5-mg sustained release: results of two randomized double-blind controlled studies.

Equivalence of indapamide SR and enalapril on microalbuminuria reduction in hypertensive patients with type 2 diabetes: the NESTOR Study.

Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III.

P304

637-645

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1472-8206.2005.00377.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16313275

http://www.w3.org/2001/XMLSchema#string